An in vitro study demonstrated that nicotinamide (a SIRT1 inhibitor) protects neurons against excitotoxicity and prevents NAD+ depletion, whereas SIRT1 may impair energetically compromised neurons by consuming NAD+ in cerebral ischemia (Liu et al., 2009). Here, SIRT1 is linked to brain ischemia.